Dysregulation of TDP-43 intracellular localization and early onset ALS are associated with a TARDBP S375G variant

Kathy Newell, Francesca Paron, Miguel Mompean, Jill Murrell, Elisa Salis, Cristiana Stuani, Gary Pattee, Maurizio Romano, Douglas Laurents, Bernardino Ghetti, Emanuele Buratti

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

We investigated the Central Nervous System (CNS) and skeletal muscle tissue from A woman was clinically diagnosed with amyotrophic lateral sclerosis (ALS) at the age of 22. Neuropathologic evaluation showed upper and lower motor neuron loss, corticospinal tract degeneration and skeletal muscle denervation. Analysis of the patient's Deoxyribonucleic acid (DNA) revealed a AGT>GGT change resulting in an S375G substitution in the C-terminal region of TDP-43. This variant was previously reported as being benign. Considering the early onset and severity of the disease in this patient, we tested the effects of this genetic variant on TDP-43 localization, pre-mRNA splicing activity and toxicity, in parallel with the effects on known neighboring disease-associated mutations. In cell lines, expressed in culture, S375G TDP-43 appeared to be more significantly localized in the nucleus and to exert higher toxicity than wild-type TDP-43. Strikingly, a phosphomimic mutant at the same residue (S375E) showed a strong tendency to accumulate in the cytoplasm, especially under stress conditions, and molecular dynamics simulations suggest that phosphorylation of this residue can disrupt TDP-43 intermolecular interactions. The results of the current study highlight the importance of phosphorylation and regulation of TDP-43 nuclear-cytoplasmic shuttling/redistribution, in relation to the pathogenetic mechanisms involved in different forms of ALS.

Original languageEnglish (US)
JournalBrain Pathology
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Amyotrophic Lateral Sclerosis
Skeletal Muscle
Phosphorylation
Muscle Denervation
Pyramidal Tracts
RNA Precursors
Motor Neurons
Molecular Dynamics Simulation
Cytoplasm
Central Nervous System
Cell Line
Muscles
Mutation
DNA

Keywords

  • ALS
  • FTLD
  • mRNA splicing
  • neurodegeneration
  • phosphorylation
  • TARDBP mutations
  • TDP-43 mutations

ASJC Scopus subject areas

  • Neuroscience(all)
  • Pathology and Forensic Medicine
  • Clinical Neurology

Cite this

Newell, K., Paron, F., Mompean, M., Murrell, J., Salis, E., Stuani, C., ... Buratti, E. (Accepted/In press). Dysregulation of TDP-43 intracellular localization and early onset ALS are associated with a TARDBP S375G variant. Brain Pathology. https://doi.org/10.1111/bpa.12680

Dysregulation of TDP-43 intracellular localization and early onset ALS are associated with a TARDBP S375G variant. / Newell, Kathy; Paron, Francesca; Mompean, Miguel; Murrell, Jill; Salis, Elisa; Stuani, Cristiana; Pattee, Gary; Romano, Maurizio; Laurents, Douglas; Ghetti, Bernardino; Buratti, Emanuele.

In: Brain Pathology, 01.01.2018.

Research output: Contribution to journalArticle

Newell, K, Paron, F, Mompean, M, Murrell, J, Salis, E, Stuani, C, Pattee, G, Romano, M, Laurents, D, Ghetti, B & Buratti, E 2018, 'Dysregulation of TDP-43 intracellular localization and early onset ALS are associated with a TARDBP S375G variant', Brain Pathology. https://doi.org/10.1111/bpa.12680
Newell, Kathy ; Paron, Francesca ; Mompean, Miguel ; Murrell, Jill ; Salis, Elisa ; Stuani, Cristiana ; Pattee, Gary ; Romano, Maurizio ; Laurents, Douglas ; Ghetti, Bernardino ; Buratti, Emanuele. / Dysregulation of TDP-43 intracellular localization and early onset ALS are associated with a TARDBP S375G variant. In: Brain Pathology. 2018.
@article{fbf1e29613dc4cb7830ae0caa8cff089,
title = "Dysregulation of TDP-43 intracellular localization and early onset ALS are associated with a TARDBP S375G variant",
abstract = "We investigated the Central Nervous System (CNS) and skeletal muscle tissue from A woman was clinically diagnosed with amyotrophic lateral sclerosis (ALS) at the age of 22. Neuropathologic evaluation showed upper and lower motor neuron loss, corticospinal tract degeneration and skeletal muscle denervation. Analysis of the patient's Deoxyribonucleic acid (DNA) revealed a AGT>GGT change resulting in an S375G substitution in the C-terminal region of TDP-43. This variant was previously reported as being benign. Considering the early onset and severity of the disease in this patient, we tested the effects of this genetic variant on TDP-43 localization, pre-mRNA splicing activity and toxicity, in parallel with the effects on known neighboring disease-associated mutations. In cell lines, expressed in culture, S375G TDP-43 appeared to be more significantly localized in the nucleus and to exert higher toxicity than wild-type TDP-43. Strikingly, a phosphomimic mutant at the same residue (S375E) showed a strong tendency to accumulate in the cytoplasm, especially under stress conditions, and molecular dynamics simulations suggest that phosphorylation of this residue can disrupt TDP-43 intermolecular interactions. The results of the current study highlight the importance of phosphorylation and regulation of TDP-43 nuclear-cytoplasmic shuttling/redistribution, in relation to the pathogenetic mechanisms involved in different forms of ALS.",
keywords = "ALS, FTLD, mRNA splicing, neurodegeneration, phosphorylation, TARDBP mutations, TDP-43 mutations",
author = "Kathy Newell and Francesca Paron and Miguel Mompean and Jill Murrell and Elisa Salis and Cristiana Stuani and Gary Pattee and Maurizio Romano and Douglas Laurents and Bernardino Ghetti and Emanuele Buratti",
year = "2018",
month = "1",
day = "1",
doi = "10.1111/bpa.12680",
language = "English (US)",
journal = "Brain Pathology",
issn = "1015-6305",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Dysregulation of TDP-43 intracellular localization and early onset ALS are associated with a TARDBP S375G variant

AU - Newell, Kathy

AU - Paron, Francesca

AU - Mompean, Miguel

AU - Murrell, Jill

AU - Salis, Elisa

AU - Stuani, Cristiana

AU - Pattee, Gary

AU - Romano, Maurizio

AU - Laurents, Douglas

AU - Ghetti, Bernardino

AU - Buratti, Emanuele

PY - 2018/1/1

Y1 - 2018/1/1

N2 - We investigated the Central Nervous System (CNS) and skeletal muscle tissue from A woman was clinically diagnosed with amyotrophic lateral sclerosis (ALS) at the age of 22. Neuropathologic evaluation showed upper and lower motor neuron loss, corticospinal tract degeneration and skeletal muscle denervation. Analysis of the patient's Deoxyribonucleic acid (DNA) revealed a AGT>GGT change resulting in an S375G substitution in the C-terminal region of TDP-43. This variant was previously reported as being benign. Considering the early onset and severity of the disease in this patient, we tested the effects of this genetic variant on TDP-43 localization, pre-mRNA splicing activity and toxicity, in parallel with the effects on known neighboring disease-associated mutations. In cell lines, expressed in culture, S375G TDP-43 appeared to be more significantly localized in the nucleus and to exert higher toxicity than wild-type TDP-43. Strikingly, a phosphomimic mutant at the same residue (S375E) showed a strong tendency to accumulate in the cytoplasm, especially under stress conditions, and molecular dynamics simulations suggest that phosphorylation of this residue can disrupt TDP-43 intermolecular interactions. The results of the current study highlight the importance of phosphorylation and regulation of TDP-43 nuclear-cytoplasmic shuttling/redistribution, in relation to the pathogenetic mechanisms involved in different forms of ALS.

AB - We investigated the Central Nervous System (CNS) and skeletal muscle tissue from A woman was clinically diagnosed with amyotrophic lateral sclerosis (ALS) at the age of 22. Neuropathologic evaluation showed upper and lower motor neuron loss, corticospinal tract degeneration and skeletal muscle denervation. Analysis of the patient's Deoxyribonucleic acid (DNA) revealed a AGT>GGT change resulting in an S375G substitution in the C-terminal region of TDP-43. This variant was previously reported as being benign. Considering the early onset and severity of the disease in this patient, we tested the effects of this genetic variant on TDP-43 localization, pre-mRNA splicing activity and toxicity, in parallel with the effects on known neighboring disease-associated mutations. In cell lines, expressed in culture, S375G TDP-43 appeared to be more significantly localized in the nucleus and to exert higher toxicity than wild-type TDP-43. Strikingly, a phosphomimic mutant at the same residue (S375E) showed a strong tendency to accumulate in the cytoplasm, especially under stress conditions, and molecular dynamics simulations suggest that phosphorylation of this residue can disrupt TDP-43 intermolecular interactions. The results of the current study highlight the importance of phosphorylation and regulation of TDP-43 nuclear-cytoplasmic shuttling/redistribution, in relation to the pathogenetic mechanisms involved in different forms of ALS.

KW - ALS

KW - FTLD

KW - mRNA splicing

KW - neurodegeneration

KW - phosphorylation

KW - TARDBP mutations

KW - TDP-43 mutations

UR - http://www.scopus.com/inward/record.url?scp=85059122357&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059122357&partnerID=8YFLogxK

U2 - 10.1111/bpa.12680

DO - 10.1111/bpa.12680

M3 - Article

C2 - 30461104

AN - SCOPUS:85059122357

JO - Brain Pathology

JF - Brain Pathology

SN - 1015-6305

ER -